A European multicenter study to assess if genetic variants in the protein-coding region or untranslated regions of the IL-17A gene are associated with response to IL-17A inhibitors in patients with psoriasis
Latest Information Update: 01 Jan 2021
At a glance
- Drugs Ixekizumab (Primary) ; Secukinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
Most Recent Events
- 01 Jan 2021 New trial record